GSK5764227 Clinical Trials
4 recruitingBiologic
Phase 13Phase 22
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
Gastrointestinal Neoplasms
GlaxoSmithKline451 enrolled85 locationsNCT06885034
Recruiting
Phase 2
A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto30 enrolled1 locationNCT07408063
Recruiting
Phase 1
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Neoplasms
GlaxoSmithKline84 enrolled6 locationsNCT07277270
Recruiting
Phase 1
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Neoplasms
GlaxoSmithKline158 enrolled26 locationsNCT05277051